
🦵 ASA after THA/TKA: conflicting trials? EPCAT III: ASA noninferior to 5-day rivaroxaban→ASA. PEPPER: noninferiority vs 30-day anticoagulation unproven. Different questions. Individualize prophylaxis. @NEJM nejm.org/doi/full/10.1056/NE… nejm.org/doi/full/10.1056/NE…
























